Pere Coll
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 29
- Microbiology top 0.5%
- Bacterial Infections and Vaccines 17
- Endocrinology top 0.5%
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology 41
-
- Mycobacterium research and diagnosis 40
- Pneumonia and Respiratory Infections 31
- Infective Endocarditis Diagnosis and Management 13
-
- Infectious Diseases and Tuberculosis 13
-
- Streptococcal Infections and Treatments 11
- Co-authors
- Ferrán NavarroBeatriz MirelisGuillem PratsElisenda MiróAlba RiveraF SánchezFrancesca MarchPeré Domingo
- Journals
- Journal of Clinical Microbiology (11 papers)Journal of Antimicrobial Chemotherapy (10 papers)Clinical Microbiology and Infection (9 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Pere Coll
154 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 139
- Molecular Medicine 1.1k
- Microbiology 140
- Endocrinology 569
- Applied Microbiology and Biotechnology 161
- Infectious Diseases 1.4k
Countries citing papers authored by Pere Coll
This map shows the geographic impact of Pere Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Coll more than expected).
Fields of papers citing papers by Pere Coll
This network shows the impact of papers produced by Pere Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Coll. The network helps show where Pere Coll may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pere Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2019 | 45 | |
| 3 | 2017 | 6 | |
| 4 | 2017 | 10 | |
| 5 | 2014 | 35 | |
| 6 | 2010 | 49 | |
| 7 | 2010 | 43 | |
| 8 | 2009 | 3 | |
| 9 | 2007 | 10 | |
| 10 | 2007 | 37 | |
| 11 | 2006 | 33 | |
| 12 | 2004 | 19 | |
| 13 | 1998 | 104 | |
| 14 | 1996 | 14 | |
| 15 | 1996 | 4 | |
| 16 | 1995 | 14 | |
| 17 | 1993 | 129 | |
| 18 | 1993 | 21 | |
| 19 | 1986 | 2 | |
| 20 | [Nocardiosis in immunosuppressed patients]. | 1985 | 0 |
About Pere Coll
Pere Coll is a scholar working on Molecular Medicine, Microbiology, Infectious Diseases, Microbiology and Epidemiology, having authored 156 papers that have together received 4.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (41 papers), Mycobacterium research and diagnosis (40 papers), Pneumonia and Respiratory Infections (31 papers), Antibiotic Resistance in Bacteria (29 papers), Bacterial Infections and Vaccines (17 papers), Infectious Diseases and Tuberculosis (13 papers), Infective Endocarditis Diagnosis and Management (13 papers) and Streptococcal Infections and Treatments (11 papers). The work is most often cited by research in Molecular Medicine (1.1k citations), Microbiology (140 citations), Endocrinology (569 citations), Applied Microbiology and Biotechnology (161 citations) and Infectious Diseases (1.4k citations). Pere Coll has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Ferrán Navarro, Beatriz Mirelis, Guillem Prats, Elisenda Miró, Alba Rivera, F Sánchez, Francesca March, Peré Domingo, Jordi Almirall and Montserrat Español. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, Clinical Infectious Diseases and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.